Skip to main content
Administration for Strategic Preparedness and Response

Administration for Strategic Preparedness and Response

Government agencyWikipedia

Search complete. 11 mentions across 9 episodes found for "Administration for Strategic Preparedness and Response".

Sep 22, 2026

Monisha AshokGUEST
13:23
And we're working very closely with the interagency here.
Monisha AshokGUEST
13:26
So this is really being driven by the White House and NSC, but also HHS and ASPR, which has their essential medicines list with DOW to look at, you know, where can we invest to strengthen these supply chains?
J. Stephen MorrisonHOST
13:41
And do you have examples you can point to in terms of active investments in this area? Or is it mostly pipeline? Is it mostly going out and trying to figure out where the next round of investments are going to be made in the coming years?
Monisha AshokGUEST
13:57
Yes, this is a somewhat new area for us.
Ira PastorHOST
32:39
And, um, there, there's someone else very interested, and that's, um, the US government.
Ira PastorHOST
32:45
And, you know, I've, um, had the opportunity to host the, you know, the BARDA and the ASPR folks on the show in the past and talk about the national stockpile and, and the, uh, the Defense Production Act.
Ira PastorHOST
32:56
Um, I, I, me- wherever that's press release, obviously this, uh, initially is TBain focused, but you know, when one reads the, you know, essential medicines, medical countermeasures, and critical inputs, I, I assume, you know, especially when we talk about tropane alkaloids and all that, maybe you're doing some chemical countermeasure stuff as well.
Ira PastorHOST
33:15
Um, to the extent you can talk about this and what you're working on, um, that's public, please, I'd love to hear about it, 'cause obviously, um, you know, whether we're talking about important critical medicines or countermeasures or everything else they work on [chuckles] down there, very important that we have a reliable source.
Christina SmolkeGUEST
37:57
It's not even limited to a class of, of medicines.
Christina SmolkeGUEST
38:00
It is very broadly applicable and so can be a very broad solution.
Christina SmolkeGUEST
38:04
Um, so to this point, you know, we have very strong relationships, um, and established partnerships with HHS through ASPR, um, and BARDA, and that's through the BioMaP consortium that was set up, um, you know, a couple of years ago.
Christina SmolkeGUEST
38:18
Um, uh, and we continue to build on those partnerships and relationships.
Jeffrey EkomaGUEST
12:11
It would be really great if Congress reauthorizes PAPA.
Jeffrey EkomaGUEST
12:16
Also, reiterating a really important point from ASPR is, is that preparedness is at its strongest when complementary capabilities exist at all levels of government with state, territorial, local, and tribal jurisdictions on the forefront.
Jeffrey EkomaGUEST
12:33
Preparedness involves taking a proactive approach that considers all key stakeholders with the response to an emergency.
John SheehanHOST
12:40
Any final thoughts?
Jonathan HowardHOST
44:49
in 2020 for whistleblowing on the Trump administration's plans to make hydroxychloroquine available over the counter for COVID-19.
Jonathan HowardHOST
44:59
And according to this, when he led ASPR, he halted an Obama-era initiative to develop a machine capable of producing about 1.5 million N95 respirators per day.
Jonathan HowardHOST
45:12
And he also lied to Congress about how many N95s were available in 2020.
Jonathan HowardHOST
45:18
He said we had 35 million, when in fact we only had 12 million.
Charity DeanGUEST
5:32
And through that lens, I founded, uh, the Public Health Company, or PHC Global, and was lucky enough to have Venrock as our lead investor.
Charity DeanGUEST
5:40
Very simply, no intelligence platform existed to give those of us, uh, myself, national security agencies, my amazing colleagues at Department of Homeland Security, my amazing colleagues that were in ASPR and HHS, and every doctor on the front lines, nothing existed for a shared common operating picture of bio-threat intelligence.
Charity DeanGUEST
6:02
So in twenty-twenty- Knowing nothing about how to build that business or how hard it would be, I set out to do it, and six years later, we have built the first of its kind, uh, AI bio-threat intelligence platform.
Charity DeanGUEST
6:18
When I founded it in 20-
Sam Weiss EvansGUEST
22:02
Okay, wait.
Sam Weiss EvansGUEST
22:03
Uh, here, you know, uh, ASPR, you go and take, and take this problem and, and deal with it.
Sam Weiss EvansGUEST
22:09
Um, ASPR, um, Administration for Pandemic Preparedness- Preparedness ... yeah, and Response.
Sam Weiss EvansGUEST
22:16
And Response.
Sam Weiss EvansGUEST
22:17
Yes.
RobHOST
24:56
And that's what Van Ryn does.
RobHOST
24:57
But everything from cyber gateways to OCR rules to ASPR, I mean, there's so many acronyms, typical government stuff.
RobHOST
25:04
But we just need to make those simplified like we do and walk you through them and make sure you're adhering to not only the law, but also protecting your business.
RobHOST
25:13
That you worked very hard to build up.
Jeffrey EkomaGUEST
3:52
She is currently the deputy assistant to the president for domestic policy at the White House.
Jeffrey EkomaGUEST
3:58
There were also lots of other folks that were actively tracking, and they include Sean Kaufman, who was nominated to be the next ASPR.
Jeffrey EkomaGUEST
4:04
Chris Klumpt, who was nominated to be the Deputy Secretary for HHS.
Jeffrey EkomaGUEST
4:09
Dr. Nicole Sapphire, who was nominated to be the next Surgeon General.
David GruschSOUNDBITE_SPEAKER
73:08
It's interesting that I think HHS and Bobby Kennedy, assuming Trump releases all the information, is going to play a big role to include.
David GruschSOUNDBITE_SPEAKER
73:15
There's an administration for strategic preparedness readiness called ASPR that would need to be involved as well to coordinate that response.
David GruschSOUNDBITE_SPEAKER
73:23
So I totally agree with you.
David GruschSOUNDBITE_SPEAKER
73:25
There's kind of an undervalued fact that you're going to have to

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.